HomeHealthcare & Life SciencesPharmaceuticals Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market

United States Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market Size & Outlook, 2026-2034


United States Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market Insights

  • Based on Reed Intelligence findings, the United States Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market reached USD 43.93 Million in 2025 and is estimated to attain USD 103.86 Million by 2034.
  • From 2026 to 2034, the United States market is expected to grow at a steady CAGR of 10%.
  • Within the Treatment Type category, Drug Therapy dominated in 2025 in terms of market size contribution.
  • Over the forecast period, Gene Therapy is forecasted to deliver the fastest growth, positioning it as the most lucrative Treatment Type segment.

Other Key Findings


  • United States accounted for 23.75% of the global Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market size in 2025.
  • By 2034, United States is expected to remain the top global market in terms of size.
  • Within North America, United States is forecasted to dominate the regional Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market size by 2034.
  • United States will be the fastest-growing market in North America, projected to achieve USD 103.58 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 43.93 Million
Market Size In 2034 USD 103.86 Million
Largest segment Drug Therapy
Units Revenue in USD Million
CAGR 10% (2026-2034)
Segmnetation Covered
Treatment Type
  1. Drug Therapy
  2. Gene Therapy
  3. Supportive Therapy
Route of Administration
  1. Oral
  2. Injectable
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Homecare Settings
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports